| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/18/2007 | CN1311077C Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/18/2007 | CN1310950C Telerance starch made of starch of de-amylopectin by iso-anylase |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/17/2007 | USRE39576 Inhibitors of inducible nitric oxide synthase, as hypotensive agent, antiinflammatory agent, antiarthritic agent |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | CA2348841C Improved growth stimulant compositions |
| 04/17/2007 | CA2271085C Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007040006A1 Activator for peroxisome proliferator-activated receptor (pparϝ) and composition containing the activator for preventing or ameliorating specific symptom |
| 04/12/2007 | WO2007040005A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPARα) AND COMPOSITION CONTAINING THE ACTIVATOR FOR PREVENTING OR AMELIORATING SPECIFIC SYMPTOM |
| 04/12/2007 | WO2007039544A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds |
| 04/12/2007 | WO2007038829A1 Method of drug design |
| 04/12/2007 | WO2007016385A3 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 04/12/2007 | WO2007011951A3 Purification of paricalcitol |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2624015A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds |
| 04/12/2007 | CA2623154A1 Novel fused pyrrole derivative |
| 04/12/2007 | CA2619457A1 Method of drug design |
| 04/11/2007 | EP1772518A2 Mammalian-type glycosylation in plants |
| 04/11/2007 | EP1772462A2 Steroid sulfamates, method for the production and use thereof |
| 04/11/2007 | EP1771461A2 Novel 2-substituted estra-1,3,5(10)-trien-17-ones used in the form of inhibitors of 17beta-hydroxysteroiddehydrogenase of type 1 |
| 04/11/2007 | EP1771193A1 Gus3 neuropeptides for regulating hypothalamic function |
| 04/11/2007 | EP1771179A2 COMPOSITIONS COMPRISING 5-ALPHA REDUCTASE INHIBITORS, AND SERMs AND METHODS OF USE THEREOF |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | CN1946689A Bazedoxifene ascorbate as selective estrogen receptor modulator |
| 04/11/2007 | CN1946427A Liquid growth hormone formulation |
| 04/11/2007 | CN1946387A Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| 04/11/2007 | CN1946382A Rapid dissolution formulation of a calcium receptor-active compound |
| 04/11/2007 | CN1943723A A Chinese traditional medicinal embolus for treatment of hyperthyroidism and its preparation method |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202239 Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7201913 Oral formulations for anti-tumor compounds |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | CA2337991C Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/10/2007 | CA2307068C Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2222068C Chimeric fatty body-pro-grf analogs with increased biological potency |
| 04/05/2007 | WO2007037438A1 Ameliorating agent for metabolic syndrome |
| 04/04/2007 | EP1770083A1 Inorganic ion receptor-active compounds |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1769799A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 04/04/2007 | EP1768976A1 Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 04/04/2007 | EP1768654A2 Selective inhibitors of human corticosteroid syntheses |
| 04/04/2007 | CN1942479A Thienopyrroles as antagonists of GnRH |
| 04/04/2007 | CN1942190A Pyrrole derivatives as gonadotropin releasing hormone (GnRH) antagonists |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308002C Compound preparation of notoginseng total saponin and quzaqi aglycone and its preparing method |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199116 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 03/29/2007 | WO2007005174A3 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 03/29/2007 | WO2006124447A3 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
| 03/29/2007 | WO2006073771A3 Polyethylene glycol linked mc4r or mc3r agonist peptides |
| 03/29/2007 | US20070072865 Bicyclic piperazine compound and use thereof |
| 03/29/2007 | US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
| 03/29/2007 | US20070072810 Agent for treating diabetes |
| 03/29/2007 | US20070072291 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070071794 Drugs for treating diabetes |
| 03/29/2007 | DE202006013518U1 Mittel zur Behandlung von neuroendokrinen gesundheitlichen Störungen Agents for the treatment of health disorders neuroendocrine |
| 03/29/2007 | CA2619093A1 Modulators of metabolism and the treatment of disorders related thereto |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767202A1 3,5,3'-Triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof |
| 03/28/2007 | EP1767198A1 Regulator of physiological function of ghrelin and use thereof |
| 03/28/2007 | EP1767195A2 Stable spray-dried protein formulations |
| 03/28/2007 | EP1765413A2 Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
| 03/28/2007 | CN1938299A Thioamide derivatives as progesterone receptor modulators |
| 03/28/2007 | CN1938272A Crystalline polymorph of bazedoxifene acetate |
| 03/28/2007 | CN1938271A Crystalline polymorph of bazedoxifene acetate |
| 03/28/2007 | CN1938018A Use of compounds that are able to increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 03/28/2007 | CN1938008A Sustained-release preparations |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307178C Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists |
| 03/28/2007 | CN1307166C Oxazole/thiazol-derivatives activators of the HPPAR-alpha receptor |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196081 Compounds with hydroxycarbonyl-halogenoalkyl side chains |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7196074 Hormone replacement therapy |
| 03/27/2007 | US7196067 Which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells; gene expression inhibition |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2168879C Skin patches and methods for providing testosterone |
| 03/22/2007 | WO2007033269A1 Composition comprising a dendrimer and the use thereof for binding phosphate |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |